C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
12/2002
12/19/2002	US20020193432 Useful as modulators of the interaction between the receptor for advanced glycated end product and its ligands
12/19/2002	US20020193414 Adamantane derivatives
12/19/2002	US20020193354 7, 9-substituted tetracycline compounds
12/19/2002	US20020192693 Apparatus for polymer synthesis
12/19/2002	US20020189033 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same
12/19/2002	CA2450557A1 Substituted aminoalcohols useful in treatment of alzheimer's disease
12/18/2002	EP1265862A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
12/18/2002	EP1265850A2 Insecticidal anthranilamides
12/18/2002	EP1265849A2 Compounds and methods to treat alzheimer's disease
12/18/2002	EP0912584B1 New bis-platinum complexes with polyamine ligands as antitumor agents
12/18/2002	CN1385417A Polyasparacyl-L-arginine, its preparation and medical application
12/17/2002	US6495715 Calcium channel blockers
12/17/2002	US6495693 N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
12/17/2002	US6495681 Local anesthetic compounds and uses
12/17/2002	US6495680 A helical composition comprising a plurality of aromatic substituents linked by at least one amide group, the composition having a curved backbone due at least in part to intramolecular hydrogen bonds that rigidify the amide linkage
12/17/2002	US6495546 Propanolamine derivatives
12/12/2002	WO2002098849A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
12/12/2002	US20020187101 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes
12/12/2002	CA2448834A1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
12/11/2002	EP1264821A1 Novel crystal of stilbene derivative and process for producing the same
12/11/2002	EP1263730A1 Amine derivatives for the treatment of apoptosis
12/11/2002	EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/11/2002	EP1263712A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
12/11/2002	EP1263442A1 TETRACYCLINE COMPOUNDS FOR TREATMENT OF i CRYPTOSPORIDIUM PARVUM /i RELATED DISORDERS
12/11/2002	EP1017378B1 Amide derivatives for the treatment of diseases mediated by cytokines
12/11/2002	EP0805796B1 Cell adhesion inhibitors
12/11/2002	CN1384814A Phenoxy carboxylic acid compounds and compositions for delivering active agents
12/10/2002	US6492553 A method for preparing a n-((aliphatic or aromatic)carbonyl) )-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
12/10/2002	US6492541 Process for the preparation of 3-amino-2-oxo-pyrrolidines, novel intermediates and their use
12/10/2002	US6492363 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives
12/10/2002	US6492355 Adamantane derivatives
12/10/2002	US6491871 System for determining receptor-ligand binding affinity
12/09/2002	WO2002004403A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
12/09/2002	CA2412116A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
12/05/2002	WO2002096360A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
12/05/2002	US20020183512 Compounds for use in treatment of cancer
12/05/2002	US20020183397 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
12/05/2002	CA2448062A1 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
12/04/2002	EP1261321A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
12/04/2002	CN1382686A Process for preparing 3-aminobenzoylamine
12/03/2002	US6489495 Cationic amphiphiles for liposomal gene transfer
12/03/2002	US6489364 From l-mannonic-gamma-lactone intermediates; for prophylaxis of hiv/aids hiv
12/03/2002	US6489327 Tryptase inhibitors
12/03/2002	US6489291 Topical composition for skin
11/2002
11/28/2002	WO2002095393A2 Drug evolution: drug design at hot spots
11/28/2002	US20020177716 Intermediates of CETP inhibitors
11/27/2002	EP1000048B1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
11/27/2002	EP0776331B1 Higher order structure and binding of peptide nucleic acids
11/27/2002	EP0671928B1 Synthesis of n-substituted oligomers
11/27/2002	CN1094943C Urethanes and ureas that induce cytokine production
11/26/2002	US6486178 Indane derivatives
11/24/2002	CA2354921A1 Drug evolution: drug design at hot spots
11/21/2002	WO2002092562A2 Enantioselective reactions using two-component chiral phase transfer catalysts in multiphasic systems
11/21/2002	WO2002092068A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/21/2002	WO2002091989A2 Antiviral therapies using polyamine or polyamine analog-amino acid conjugates
11/21/2002	WO2002042271A3 Biphenylcarboxamides useful as lipid lowering agents
11/21/2002	US20020173664 An 3-acyl-4-substituted-oxazolidin-2,5-dione that readily reacts with nucleophilic reagents such as free amino acids; use in peptide synthesis for example
11/21/2002	US20020173543 Compounds for altering mitochondrial function and cellular responses
11/21/2002	CA2446593A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
11/20/2002	EP1258492A1 N-substituted oligomers and methods for their synthesis, e.g. polyglycine bearing nucleic acid bases
11/20/2002	EP1257527A1 (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands
11/20/2002	EP1257521A1 Method for the production of amines from epoxidised olefins
11/20/2002	EP1257265A2 Use of 2-phenylene diamine derivatives for the treatment of infections
11/20/2002	CN1094484C Process for purifying terramycin
11/19/2002	US6482943 Quinones as disease therapies
11/19/2002	US6482859 Microbicidal N-sulfonylglycin alkynyloxyphenethyl amide derivatives
11/19/2002	US6482852 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
11/19/2002	US6482849 Inhibitors of α4β1 mediated cell adhesion
11/14/2002	WO2002089789A1 Trimethyl lock based tetrapartate prodrugs
11/14/2002	WO2002064616A3 Agonists and antagonists of sphingosine-1-phosphate receptors
11/14/2002	US20020169326 Fatty acid derivatives
11/14/2002	US20020169157 An aromatic or heteroaromatic amino acid derivative, used for treating disorders related to overexpression of protein tyrosine phosphatase-1B
11/14/2002	CA2445065A1 Trimethyl lock based tetrapartate prodrugs
11/13/2002	EP1256576A1 Fused imidazolium derivatives
11/13/2002	EP1255726A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/13/2002	EP1255724A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds
11/13/2002	EP0966428B1 PROCESS FOR THE CRYSTALLIZATION FROM A LINEAR OR BRANCHED (C5-C6) ALCOHOL OR THEIR MIXTURES OF (S)-N,N'-bis 2-HYDROXY-1- (HYDROXYMETHYL)ETHYL]-5- (2-HYDROXY-1-OXOPROPYL)AMINO]-2,4,6- TRIIODO-1,3-BENZENEDICARBOXAMIDE
11/13/2002	EP0920413B1 Boronic compound complexing reagents and complexes
11/13/2002	EP0699074B1 Thrombin inhibitors
11/13/2002	CN1379819A Catalytically active recombinant MEMAPSIN and methods of use thereof
11/13/2002	CN1379756A Substituted nor bornylamino derivatives, method for production thereof, use thereof as medicament or diagnostic reagent medicaments containing said compounds
11/12/2002	US6479587 Crosslinkable polyurea polymers
11/12/2002	US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/12/2002	US6479548 Substituted stilbenes as glucose uptake enhancers
11/12/2002	US6479484 Substituted 2-aminoacetamides and the discovery that these compounds act as blockers of sodium channels; pain relievers, treatment of arrythmia, local anesthetics
11/07/2002	WO2002088085A2 Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors
11/07/2002	WO2002088069A2 Compounds useful as intermediates for 4-aminoquinoline derivatives
11/07/2002	WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002	WO2001047866A9 Substituted 1 and 2 naphthol mannich bases
11/07/2002	WO2001046220A3 Bioactive oligopeptides
11/07/2002	US20020165402 Quarternary ammonium compounds
11/07/2002	US20020165398 Amino-thiophene-amido derivatives
11/07/2002	US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165230 Gamma-ketoacid dipeptides as inhibitors of caspase-3
11/07/2002	US20020164760 Catalytically active recombinant memapsin and methods of use thereof
11/07/2002	US20020164360 Topical applying peptide to skin
11/07/2002	CA2445693A1 Compounds useful as intermediates for 4-aminoquinoline derivatives
11/07/2002	CA2445623A1 Methods for preparing cetp inhibitors
11/06/2002	EP1254092A1 Resolution of dl-racemic mixtures

1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 162